{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:41Z","timestamp":1761895601250},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/hjh.0b013e32835d2c6c","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T15:24:27Z","timestamp":1360164267000},"page":"S9-S12","source":"Crossref","is-referenced-by-count":30,"title":["Therapeutic strategies to improve control of hypertension"],"prefix":"10.1097","volume":"31","author":[{"given":"Pedro","family":"Armario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Waeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210208","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.","volume":"338","author":"Law","year":"2009","journal-title":"Br Med J"},{"key":"R2-3-20210208","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.HYP.0000103630.72812.10","article-title":"Hypertension treatment and control in five European countries, Canada and the United States.","volume":"43","author":"Wolf-Maier","year":"2004","journal-title":"Hypertension"},{"key":"R3-3-20210208","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/eurheartj\/ehr080","article-title":"Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe. the EURIKA study.","volume":"32","author":"Banegas","year":"2011","journal-title":"Eur Heart J"},{"key":"R4-3-20210208","first-page":"385","article-title":"High-risk patients with hypertension: are we doing enough J Am Soc H","volume":"2","author":"Chiao","year":"2008","journal-title":"ypertens"},{"key":"R5-3-20210208","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.hjh.0000202819.48577.a1","article-title":"Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study.","volume":"24","author":"Marin","year":"2006","journal-title":"J Hypertens"},{"key":"R6-3-20210208","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/HJH.0b013e328348efa7","article-title":"Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey.","volume":"29","author":"Prugger","year":"2011","journal-title":"J Hypertens"},{"key":"R7-3-20210208","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.","volume":"303","author":"Egan","year":"2010","journal-title":"J Am Med Assoc"},{"key":"R8-3-20210208","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cjca.2011.12.012","article-title":"Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension.","volume":"28","author":"Gee","year":"2012","journal-title":"Can J Cardiol"},{"key":"R9-3-20210208","first-page":"366","article-title":"The Canadian effort to prevent and control hypertension: can other countries adopt Canadian strategies Curr Opin C","volume":"25","author":"Campbell","year":"2010","journal-title":"ardiol"},{"key":"R10-3-20210208","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes.","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"R11-3-20210208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.HYP.0000200702.76436.4b","article-title":"Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals.","volume":"47","author":"Okonofua","year":"2006","journal-title":"Hypertension"},{"issue":"Suppl 4","key":"R12-3-20210208","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.hjh.0000343507.74401.45","article-title":"Practical solutions to the challenges of uncontrolled hypertension: a white paper.","volume":"26","author":"Redon","year":"2008","journal-title":"J Hypertens"},{"key":"R13-3-20210208","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11606-009-1240-1","article-title":"Antihypertensive medicaton adherence, ambulatory visits, and risk of stroke and death.","volume":"25","author":"Bailey","year":"2010","journal-title":"J Gen Intern Med"},{"key":"R14-3-20210208","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/HJH.0b013e328342ca97","article-title":"Better compliance to antihypertensive medications reduces cardiovascular risk.","volume":"29","author":"Corrao","year":"2011","journal-title":"J Hypertens"},{"key":"R15-3-20210208","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality.","volume":"333","author":"Simpson","year":"2006","journal-title":"Br Med J"},{"key":"R16-3-20210208","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/eurheartj\/ehq297","article-title":"Strategies to improve drug adherence.","volume":"32","author":"Laufs","year":"2011","journal-title":"Eur Heart J"},{"key":"R17-3-20210208","first-page":"552","article-title":"Treatment intensification in a hypertension telemanagement trial.","volume":"58","author":"Crowley","year":"2011","journal-title":"Clinical inertia or good clinical judgment Hypertension"},{"key":"R18-3-20210208","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinternmed.2011.399","article-title":"Impact of pharmacist care in the management of cardiovascular disease risk factors. A systematic review and meta-analysis of randomized trials.","volume":"171","author":"Santschi","year":"2011","journal-title":"Arch Intern Med"},{"key":"R19-3-20210208","doi-asserted-by":"crossref","first-page":"c3995","DOI":"10.1136\/bmj.c3995","article-title":"Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis.","volume":"341","author":"Clark","year":"2010","journal-title":"Br Med J"},{"key":"R20-3-20210208","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCULATIONAHA.109.892778","article-title":"Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (The COM99 Study).","volume":"122","author":"Pladevall","year":"2010","journal-title":"Circulation"},{"key":"R21-3-20210208","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jash.2011.01.001","article-title":"on behalf of the American Society of Hypertension Writing GroupAdherence and persistence with taking medication to control high blood pressure.","volume":"5","author":"Hill","year":"2011","journal-title":"J Am Soc Hypertens"},{"key":"R22-3-20210208","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/CIRCULATIONAHA.110.983874","article-title":"Meta-analysis. Impact of drugs class on adherence to antihypertensive.","volume":"123","author":"Kronish","year":"2011","journal-title":"Circulation"},{"key":"R23-3-20210208","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: Meta-analysis on 11000 participants from 42 trials.","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"R24-3-20210208","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.HYP.0000250557.63490.55","article-title":"Effectiveness of blood pressure control outside in the medical setting.","volume":"49","author":"Banegas","year":"2007","journal-title":"Hypertension"},{"key":"R25-3-20210208","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/jhh.2008.117","article-title":"and the National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trialReason for therapeutic inertia when managing hypertension in clinical practice in non-Western countries.","volume":"23","author":"Ferrari","year":"2009","journal-title":"J Hum Hypertens"},{"key":"R26-3-20210208","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/HJH.0b013e32834e90d8","article-title":"Left ventricular hypertrophy and renal dysfunction during antihypertensive treatment adversely affects cardiovascular prognosis in hypertensive patients.","volume":"30","author":"Salvetti","year":"2012","journal-title":"J Hypertens"},{"key":"R27-3-20210208","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/HJH.0b013e3283525715","article-title":"Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers.","volume":"30","author":"Volpe","year":"2012","journal-title":"J Hypertens"},{"key":"R28-3-20210208","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"2007 ESH-ESC Practice guidelines for the management of arterial hypertension. ESH-ESC Task Force on the Management of Arterial Hypertension.","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R29-3-20210208","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"R30-3-20210208","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00004872-200404000-00029","article-title":"Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.","volume":"22","author":"Staessen","year":"2004","journal-title":"J Hypertens"},{"key":"R31-3-20210208","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.110.160291","article-title":"Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications.","volume":"56","author":"Kostis","year":"2010","journal-title":"Hypertension"},{"key":"R32-3-20210208","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2165\/11316710-000000000-00000","article-title":"Fixed-dose combinations as initial therapy for hypertension. A review of approved agents and a guide to patient selection.","volume":"69","author":"Waeber","year":"2009","journal-title":"Drugs"},{"key":"R33-3-20210208","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.111.177592","article-title":"Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice.","volume":"58","author":"Corrao","year":"2011","journal-title":"Hypertension"},{"key":"R34-3-20210208","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-combinations improve medication compliance: a meta-analysis.","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am J Med"},{"key":"R35-3-20210208","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/HYPERTENSIONAHA.108.123455","article-title":"A simplified approach to the treatment of uncomplicated hypertension. A cluster randomized, controlled trial.","volume":"53","author":"Feldman","year":"2009","journal-title":"Hypertension"},{"key":"R36-3-20210208","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjmed.2010.08.007","article-title":"Effect of renin-angiotesin system blockade on calcium channel blocker-associated peripheral edema.","volume":"124","author":"Makani","year":"2011","journal-title":"Am J Med"},{"key":"R37-3-20210208","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.109.131300","article-title":"Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide. A randomized clinical trial.","volume":"54","author":"Calhoun","year":"2009","journal-title":"Hypertension"},{"key":"R38-3-20210208","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.clinthera.2010.07.008","article-title":"Triple therapy con olmesartanmedoximil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINIT multicenter, randomized, double-blind, 12-week, parallel-group study.","volume":"32","author":"Oparil","year":"2010","journal-title":"Clin Ther"},{"key":"R39-3-20210208","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.","volume":"57","author":"De la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"R40-3-20210208","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"R41-3-20210208","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","article-title":"Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events. Systematic review and network meta-analysis.","volume":"59","author":"Roush","year":"2012","journal-title":"Hypertension"},{"key":"R42-3-20210208","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1345\/aph.1P338","article-title":"Spironolactone management of resistant hypertension.","volume":"44","author":"Marrs","year":"2010","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e32835d2c6c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:40:04Z","timestamp":1621885204000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201303001-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":42,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32835d2c6c","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}